Detalles de la búsqueda
1.
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.
Circulation
; 147(18): 1358-1368, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871230
2.
Effect of rosuvastatin 20 mg versus rosuvastatin 5 mg plus ezetimibe on statin side-effects in elderly patients with atherosclerotic cardiovascular disease: Rationale and design of a randomized, controlled SaveSAMS trial.
Am Heart J
; 261: 45-50, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36934981
3.
Clinical Characteristics and Outcome of Immediate-Release Versus SLOW-Release Carvedilol in Heart Failure Patient (SLOW-HF): a Prospective Randomized, Open-Label, Multicenter Study.
Cardiovasc Drugs Ther
; 37(3): 529-537, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066737
4.
Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
Circulation
; 143(11): 1081-1091, 2021 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33205662
5.
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
Clin Ther
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704294
6.
A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.
Am J Cardiovasc Drugs
; 23(4): 441-454, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395974
7.
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial.
Eur Heart J Cardiovasc Pharmacother
; 9(3): 262-270, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715152
8.
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension.
J Clin Hypertens (Greenwich)
; 25(5): 429-439, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37095689
9.
Potential of right to left ventricular volume ratio measured on chest CT for the prediction of pulmonary hypertension: correlation with pulmonary arterial systolic pressure estimated by echocardiography.
Eur Radiol
; 22(9): 1929-36, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22538630
10.
A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.
J Clin Med
; 11(2)2022 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35054044
11.
Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial.
Clin Ther
; 44(4): 508-528, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35410753
12.
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
J Clin Hypertens (Greenwich)
; 24(10): 1298-1309, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094783
13.
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy.
Clin Hypertens
; 28(1): 40, 2022 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36451242
14.
Algorithm for diagnosing hypertension using out-of-office blood pressure measurements.
J Clin Hypertens (Greenwich)
; 23(11): 1965-1974, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699680
15.
Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III Study.
Clin Ther
; 43(9): 1573-1589, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34429197
16.
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension.
Clin Ther
; 43(10): 1746-1756, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34503866
17.
Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study.
Drug Des Devel Ther
; 14: 5735-5746, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33408462
18.
A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.
J Clin Hypertens (Greenwich)
; 22(2): 261-269, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32003938
19.
Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Diabetes Metab J
; 44(1): 78-90, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31237134
20.
Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study.
Clin Ther
; 41(8): 1508-1521, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307833